Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
37.83
-0.37 (-0.97%)
Jun 5, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Low Molecular Weight Heparin Preparations | 779.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Low Molecular Weight Heparin Preparations Growth | -35.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Unfractionated Heparin Active Pharmaceutical Ingredients | 334.76M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Unfractionated Heparin Active Pharmaceutical Ingredients Growth | -43.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Low Molecular Weight Heparin Active Pharmaceutical Ingredients | 110.14M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Low Molecular Weight Heparin Active Pharmaceutical Ingredients Growth | -74.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Unfractionated Heparin Preparations | 50.27M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Unfractionated Heparin Preparations Growth | 41.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 135.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 114.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
China | 1.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -29.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Foreign | 208.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Foreign Growth | -66.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|